More U.S. companies have become entangled in the controversy over suspicious timing of stock option grants to top executives. Several disclosed this week that they are under scrutiny by federal authorities.

In expanding investigations, at least 51 public companies are under scrutiny by the Securities and Exchange Commission or the Justice Department for possible manipulation of options grants to boost their value to the recipients.